Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20134268rdf:typepubmed:Citationlld:pubmed
pubmed-article:20134268lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0079441lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0082420lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C1366583lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0677886lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C1171892lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:20134268lifeskim:mentionsumls-concept:C1514162lld:lifeskim
pubmed-article:20134268pubmed:issue2lld:pubmed
pubmed-article:20134268pubmed:dateCreated2010-2-5lld:pubmed
pubmed-article:20134268pubmed:abstractTextSerum CD105 has been associated with angiogenic activity in cancer, and low CD105 expression has been associated with improved prognosis. The present study evaluated the prognostic significance of serum levels of CD105 and related factors in patients with epithelial ovarian cancer (EOC) after cytoreductive surgery and chemotherapy.lld:pubmed
pubmed-article:20134268pubmed:languageenglld:pubmed
pubmed-article:20134268pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:citationSubsetIMlld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20134268pubmed:statusMEDLINElld:pubmed
pubmed-article:20134268pubmed:monthFeblld:pubmed
pubmed-article:20134268pubmed:issn1525-1438lld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:DimopoulosMel...lld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:TerposEvangel...lld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:GikaDimitraDlld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:BamiasAristot...lld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:BozasGeorgeGlld:pubmed
pubmed-article:20134268pubmed:authorpubmed-author:KaradimouAlex...lld:pubmed
pubmed-article:20134268pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20134268pubmed:volume20lld:pubmed
pubmed-article:20134268pubmed:ownerNLMlld:pubmed
pubmed-article:20134268pubmed:authorsCompleteYlld:pubmed
pubmed-article:20134268pubmed:pagination248-54lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:meshHeadingpubmed-meshheading:20134268...lld:pubmed
pubmed-article:20134268pubmed:year2010lld:pubmed
pubmed-article:20134268pubmed:articleTitlePrechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.lld:pubmed
pubmed-article:20134268pubmed:affiliationDepartment of Clinical Therapeutics, University of Athens, Athens, Greece.lld:pubmed
pubmed-article:20134268pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:7042entrezgene:pubmedpubmed-article:20134268lld:entrezgene
entrez-gene:7422entrezgene:pubmedpubmed-article:20134268lld:entrezgene
entrez-gene:2022entrezgene:pubmedpubmed-article:20134268lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20134268lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20134268lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20134268lld:entrezgene